ASX:PBP Probiotec (PBP) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Probiotec Stock (ASX:PBP) 30 days 90 days 365 days Advanced Chart Get Probiotec alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume26,253 shsAverage VolumeN/AMarket CapitalizationA$242.34 millionP/E Ratio21.99Dividend Yield2.43%Price TargetN/AConsensus RatingN/A Company Overview Probiotec Limited engages in the development, manufacture, packing, distribution, and sale of prescription and over the counter pharmaceuticals, complementary medicines and consumer health products, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coatings; blister packs, bottles, sachets, tubs, and tubes; liquids, creams, gels, lotions, ointments, and powders and powder blends. It is also involved in analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia. Read More Receive PBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Probiotec and its competitors with MarketBeat's FREE daily newsletter. Email Address PBP Stock News HeadlinesMoneyTalks: Brokers name ASX-listed health stocks Percheron and Probiotec as ones to watchApril 8, 2024 | msn.com2 Incredible Dividend Growers to Buy Hand Over Fist in MarchMarch 27, 2024 | ca.finance.yahoo.comThis Crypto Is Set to Explode in JanuaryFree summit reveals where Bitcoin goes after $120k Don't miss this rare opportunity to learn directly from the experts who are driving this market…August 2 at 2:00 AM | Crypto 101 Media (Ad)Probiotec (ASX:PBP) shareholders have earned a 15% CAGR over the last five yearsMarch 27, 2024 | finance.yahoo.comProbiotec Limited's (ASX:PBP) CEO Compensation Is Looking A Bit Stretched At The MomentNovember 8, 2023 | finance.yahoo.comProbiotec's (ASX:PBP) investors will be pleased with their strong 103% return over the last five yearsOctober 6, 2023 | finance.yahoo.comWhile insiders own 31% of Probiotec Limited (ASX:PBP), retail investors are its largest shareholders with 41% ownershipSeptember 19, 2023 | finance.yahoo.comInvesco S&P 500 BuyWrite ETF (ARCA:PBP), Quotes and News SummaryAugust 29, 2023 | benzinga.comSee More Headlines PBP Stock Analysis - Frequently Asked Questions How were Probiotec's earnings last quarter? Probiotec Limited (ASX:PBP) announced its quarterly earnings results on Tuesday, February, 26th. The company reported $0.02 EPS for the quarter. Probiotec had a trailing twelve-month return on equity of 13.26% and a net margin of 5.15%. What other stocks do shareholders of Probiotec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Probiotec investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU). Company Calendar Last Earnings2/26/2019Today8/02/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:PBP CIKN/A Webwww.probiotec.com.au Phone61 3 9278 7555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.10 Trailing P/E Ratio21.99 Forward P/E RatioN/A P/E GrowthN/ANet IncomeA$8.69 million Net Margins5.15% Pretax MarginN/A Return on Equity13.26% Return on Assets5.09% Debt Debt-to-Equity Ratio100.87 Current Ratio0.81 Quick Ratio1.04 Sales & Book Value Annual SalesA$221.22 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow16.79 Book ValueA$1.07 per share Price / BookN/AMiscellaneous Outstanding Shares81,320,000Free FloatN/AMarket CapA$242.34 million OptionableNot Optionable Beta0.44 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (ASX:PBP) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Probiotec Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Probiotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.